Subscribe To
MYNZ / Mainz Biomed: Sharp Appreciation In Value Since IPO
MYNZ News
By InvestorPlace
November 1, 2023
Why Is Mainz Biomed (MYNZ) Stock Moving Today?
Mainz Biomed (NASDAQ: MYNZ ) stock is on the move Wednesday after the molecular genetics cancer diagnostic company shared results from a colorectal c more_horizontal
By GlobeNewsWire
September 27, 2023
Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
Clinical trial evaluating the Company's novel mRNA biomarkers demonstrated sensitivity for colorectal cancer of 94% with specificity of 97% and advanc more_horizontal
By GlobeNewsWire
September 20, 2023
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a m more_horizontal
By GlobeNewsWire
August 29, 2023
Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
Company Anticipates Read Outs of the Clinical Data from its EU and US Feasibility Studies this September and in Q4 Company Anticipates Read Outs of th more_horizontal
By GlobeNewsWire
March 21, 2023
Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
BERKELEY, Calif. and MAINZ, Germany, March 21, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a mol more_horizontal
By GlobeNewsWire
September 1, 2022
Mainz Biomed to Present at the H.C. Wainwright Annual Global Investment Conference
BERKELEY, Calif. and MAINZ, Germany, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a m more_horizontal
By GlobeNewsWire
May 17, 2022
Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference
BERKELEY, Calif. and MAINZ, Germany, May 17, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a mol more_horizontal
By The Motley Fool
January 26, 2022
Why Mainz Biomed Stock Is Crashing Today
The molecular genetics diagnostic company announced the pricing of a follow-on stock offering. more_horizontal